269 related articles for article (PubMed ID: 20147844)
21. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.
Villarreal FJ; Griffin M; Omens J; Dillmann W; Nguyen J; Covell J
Circulation; 2003 Sep; 108(12):1487-92. PubMed ID: 12952845
[TBL] [Abstract][Full Text] [Related]
22. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
Ikonomidis JS; Hendrick JW; Parkhurst AM; Herron AR; Escobar PG; Dowdy KB; Stroud RE; Hapke E; Zile MR; Spinale FG
Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H149-58. PubMed ID: 15598866
[TBL] [Abstract][Full Text] [Related]
23. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
[TBL] [Abstract][Full Text] [Related]
24. Early administration of Enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction.
González GE; Wilensky L; Cassaglia P; Morales C; Gelpi RJ
Cardiovasc Pathol; 2016; 25(3):208-213. PubMed ID: 26897484
[TBL] [Abstract][Full Text] [Related]
25. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
26. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
27. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
Nishiya D; Omura T; Shimada K; Matsumoto R; Kusuyama T; Enomoto S; Iwao H; Takeuchi K; Yoshikawa J; Yoshiyama M
J Pharmacol Sci; 2006 May; 101(1):31-9. PubMed ID: 16717399
[TBL] [Abstract][Full Text] [Related]
28. Progressive Reduction in Myocyte Autophagy After Myocardial Infarction in Rabbits: Association with Oxidative Stress and Left Ventricular Remodeling.
Chi RF; Wang JP; Wang K; Zhang XL; Zhang YA; Kang YM; Han XB; Li B; Qin FZ; Fan BA
Cell Physiol Biochem; 2017; 44(6):2439-2454. PubMed ID: 29268264
[TBL] [Abstract][Full Text] [Related]
29. Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction.
Balsam LB; Kofidis T; Robbins RC
J Surg Res; 2005 Apr; 124(2):194-200. PubMed ID: 15820248
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.
Buss SJ; Muenz S; Riffel JH; Malekar P; Hagenmueller M; Weiss CS; Bea F; Bekeredjian R; Schinke-Braun M; Izumo S; Katus HA; Hardt SE
J Am Coll Cardiol; 2009 Dec; 54(25):2435-46. PubMed ID: 20082935
[TBL] [Abstract][Full Text] [Related]
31. Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic
Thorn SL; Barlow SC; Feher A; Stacy MR; Doviak H; Jacobs J; Zellars K; Renaud JM; Klein R; deKemp RA; Khakoo AY; Lee T; Spinale FG; Sinusas AJ
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009055. PubMed ID: 31707811
[TBL] [Abstract][Full Text] [Related]
32. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.
Lindsey ML; Gannon J; Aikawa M; Schoen FJ; Rabkin E; Lopresti-Morrow L; Crawford J; Black S; Libby P; Mitchell PG; Lee RT
Circulation; 2002 Feb; 105(6):753-8. PubMed ID: 11839633
[TBL] [Abstract][Full Text] [Related]
33. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.
Etoh T; Joffs C; Deschamps AM; Davis J; Dowdy K; Hendrick J; Baicu S; Mukherjee R; Manhaini M; Spinale FG
Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H987-94. PubMed ID: 11514263
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs.
Yarbrough WM; Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Escobar GP; Joffs C; Lucas DG; Crawford FA; Spinale FG
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):602-10. PubMed ID: 12658202
[TBL] [Abstract][Full Text] [Related]
35. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Ikeuchi M; Shiomi T; Matsusaka H; Kubota T; Imanaka-Yoshida K; Itoh T; Takeshita A
Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1229-35. PubMed ID: 12775562
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
37. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
[TBL] [Abstract][Full Text] [Related]
38. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ
JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects.
Ruetten H; Badorff C; Ihling C; Zeiher AM; Dimmeler S
J Am Coll Cardiol; 2001 Dec; 38(7):2063-70. PubMed ID: 11738316
[TBL] [Abstract][Full Text] [Related]
40. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.
Iyer RP; Patterson NL; Zouein FA; Ma Y; Dive V; de Castro Brás LE; Lindsey ML
Int J Cardiol; 2015 Apr; 185():198-208. PubMed ID: 25797678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
